Enveric Biosciences Inc (ENVB)
0.98
+0.05
(+5.89%)
USD |
NASDAQ |
May 03, 16:00
0.9616
-0.02
(-1.88%)
Pre-Market: 20:00
Enveric Biosciences Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
March 31, 2020 | 0.7878 |
December 31, 2019 | 0.4595 |
September 30, 2019 | 0.3346 |
June 30, 2019 | 0.4618 |
March 31, 2019 | 0.4647 |
December 31, 2018 | 0.484 |
September 30, 2018 | 0.1615 |
June 30, 2018 | 0.2691 |
March 31, 2018 | 0.3103 |
December 31, 2017 | 0.3694 |
September 30, 2017 | 0.5735 |
June 30, 2017 | 0.5214 |
March 31, 2017 | 0.4488 |
December 31, 2016 | 0.4314 |
September 30, 2016 | 2.252 |
June 30, 2016 | 2.864 |
March 31, 2016 | -8.096 |
September 30, 2015 | 5.476 |
June 30, 2015 | 4.471 |
March 31, 2015 | 0.00 |
December 31, 2014 | 0.00 |
September 30, 2014 | 0.00 |
June 30, 2014 | 0.00 |
March 31, 2014 | 0.0913 |
December 31, 2013 | -0.0989 |
Date | Value |
---|---|
September 30, 2013 | -0.8581 |
June 30, 2013 | -0.8724 |
March 31, 2013 | -0.8076 |
December 31, 2012 | -0.3987 |
September 30, 2012 | 0.00 |
June 30, 2012 | 0.00 |
March 31, 2012 | 0.00 |
December 31, 2011 | 0.00 |
September 30, 2011 | 0.00 |
June 30, 2011 | 0.00 |
March 31, 2011 | 0.00 |
December 31, 2010 | 0.00 |
September 30, 2010 | 0.00 |
June 30, 2010 | 0.00 |
March 31, 2010 | 0.00 |
December 31, 2009 | 0.00 |
September 30, 2009 | 0.00 |
June 30, 2009 | 0.00 |
March 31, 2009 | 0.00 |
December 31, 2008 | 0.00 |
September 30, 2008 | 0.00 |
June 30, 2008 | 0.00 |
March 31, 2008 | 0.00 |
December 31, 2007 | 0.0062 |
September 30, 2007 | 0.0151 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.3346
Minimum
Sep 2019
0.7878
Maximum
Mar 2020
0.5109
Average
0.4607
Median
Debt to Equity Ratio Benchmarks
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 4.300M |
Total Liabilities (Quarterly) | 2.344M |
Shareholders Equity (Quarterly) | 1.956M |